Most cited papers from Vtesse (United States)
What are the most cited papers from Vtesse (United States)?
The most cited paper from Vtesse (United States) is "Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial" (Daniel S. Ory et al., 2017), with 327 citations. Next come "Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1" (36) and "Phase 1/2 evaluation of intrathecal 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick disease type C1" (5).
Showing 3 of 3 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial Daniel S. Ory et al. · The Lancet | 10 Aug 2017 | 327 |
| 2 | Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 Alfred L. Yergey, Paul S. Blank, Stephanie M. Cologna et al. · PLoS ONE | 17 Apr 2017 | 36 |
| 3 | Phase 1/2 evaluation of intrathecal 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick disease type C1 Forbes D. Porter, Nicole Yanjanin Farhat, Elizabeth A. Ottinger et al. · Molecular Genetics and Metabolism | Feb 2016 | 5 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.